Novel method for facial rejuvenation using Er:YAG laser equipped with a spatially modulated ablation module: An open prospective uncontrolled cohort study.
Journal of CosmetiC and laser therapy 2017, Vol. 19, no. 1, 25–29 N.V. Volkova*, L.K. Glazkova**, V.V. Khomchenko*** and N.S. Sadick****
*Dermatologist, Aesthetic Laser Clinician, Aesthetic Medicine Department, Ural State Medical University, Ekaterinburg, Russia;
**Dermatologist, Department of Skin Diseases, Aesthetic Medicine Department, Ural State Medical University, Ekaterinburg, Russia;
***Head of Research and Development, Director of LINLINE Medical Systems, Developer of the RecoSMA Technology, Minsk, Republic of Belarus;
****Dermatology, Weill Cornell Medical College, President of Sadick Dermatology, New York, New York, USA
Abstract: Facial aging is a complex biological process that affects the skin and superficial musculoaponeurotic system (SMAS). A new technology (RecoSMA) for skin rejuvenation based on acoustic-interference method using Er:YAG laser (2936 nm) equipped with a special module SMA that targets both the dermis and SMAS was evaluated in an open-label prospective cohort study of 100 female patients treated for facial rejuvenation. Measure of clinical improvement included investigator-rated clinical photography using the Modified Fitzpatrick Wrinkle Scale, and ultrasound measurements in the dermis a week, 30 days and six months post treatment. All patients completed the study and no complications were noted. Improvements in skin tone and texture were noted in all participants and significant decrease in wrinkle depth was demonstrated at the six-month follow-up that was confirmed by ultrasound skin measurements. Data presented herein confirm the safety and efficacy of RecoSMA treatment for facial rejuvenation.